Page 19 - Primary Sclerosing Cholangitis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Chemomab Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update

/PRNewswire/ Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical-stage biotechnology company focused on the discovery and development of innovative.

United statesUnited kingdomCity ofIlan vakninIrina kofflerDale pfostBarbara lindheimJill quigleyBristol myers squibbJillm quigleyEuropean congressDrug monitoring committeeLifesci advisorsCompugen ltdChemomab therapeutics ltdSecurities life sciences

Rare Liver Disease Summit Seeks to Improve Patient Health Outcomes

/PRNewswire/ The American Liver Foundation (ALF) will bring together leading rare liver disease experts and clinicians, patients, caregivers, advocacy.

United statesBruce dimmigIntrahepatic cholestasisLorraine stiehlTheo hellerVertex pharmaceuticalsEverylife foundation for rare diseasesNational institutes of healthAmerican liver foundationRare liver disease summitChief executive officerAmerican liverTranslational hepatology sectionNational institutesAcute hepatic porphyriaAlagille syndrome

Pliant Therapeutics Announces Presentations at the International Liver Congress™ 2022 Highlighting Preclinical and Clinical Data in Support of the INTEGRIS-PSC Phase 2a Clinical Trial

Pliant Therapeutics Announces Presentations at the International Liver Congress™ 2022 Highlighting Preclinical and Clinical Data in Support of the INTEGRIS-PSC Phase 2a Clinical Trial
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofChristopher keenanPliant therapeutics incDrug administrationCorporate communicationsEuropean medicines agencyInternational liver congressPliant therapeuticsEuropean associationChief medical offerPrimary sclerosing cholangitisPortal pressureLiver fibrosisFast track designationOrphan drug designation

Gilead to Present Latest Data From Across Liver Disease Development Programs at the International Liver Congress™ 2022

Gilead to Present Latest Data From Across Liver Disease Development Programs at the International Liver Congress™ 2022

United statesFoster cityJacquie rossTenofovir alafenamideJeff eggertMerdad parseyRisk of developmentGilead sciencesEuropean commissionWorld health organizationDrug administrationGilead sciences incExchange commissionAnalysis from national hospital discharge records databaseGilead public affairsGilead on twitter sciences

Pliant Therapeutics Inc (PLRX) Reports Presentation Highlighting Preclinical and Clinical Data in Support of the INTEGRIS-PSC Phase 2a Clinical Trial

Pliant Therapeutics Inc (PLRX) Reports Presentation Highlighting Preclinical and Clinical Data in Support of the INTEGRIS-PSC Phase 2a Clinical Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofPliant therapeutics incInternational liver congressWall streetEuropean associationChief medical offerPrimary sclerosing cholangitisPortal pressureLiver fibrosis